8 Best Pot Stocks to Buy
The history of the cannabis industry is riddled with changes and conflicting legislation. The international media has played an important role in shifting perspectives about marijuana and drug use.
Jazz Pharmaceuticals Plc (JAZZ)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Polaris Capital Management Bernard Horn | 1,432,660 | $172,520,917 | +14% | 8.59% |
| 2. | Vestal Point Capital Ryan Wilder | 1,100,000 | $132,462,000 | +52% | 10.95% |
| 3. | EcoR1 Capital Oleg Nodelman | 1,013,952 | $122,100,100 | 3.08% | |
| 4. | AQR Capital Management Cliff Asness | 744,646 | $89,670,271 | +145% | 0.15% |
| 5. | Avidity Partners Management David Witzke And Michael Gregory | 584,000 | $70,325,280 | +20% | 2.26% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $119.65 | 12,000 | Officer | 27,932 | 2024-03-01 | Filing | |
| $112.32 | 11,482 | Director | 1,152,788 | 2020-05-27 | Filing | |
| $111.56 | 9,884 | Director | 1,141,306 | 2020-05-27 | Filing | |
| $110.52 | 8,391 | Director | 1,131,422 | 2020-05-27 | Filing | |
| $109.55 | 5,243 | Director | 1,123,031 | 2020-05-27 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $108.83 | 163 | Officer | 6,596 | 2024-06-07 | Filing | |
| $109.65 | 5,000 | Officer | 36,629 | 2024-05-03 | Filing | |
| $116.98 | 1,768 | Officer | 6,596 | 2024-03-07 | Filing | |
| $117.51 | 700 | Officer | 8,364 | 2024-03-06 | Filing | |
| $120.85 | 1,236 | Officer | 9,064 | 2024-03-06 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 7,056,032 | $867,891,936 | 0.02% | |
| 2. | 6,363,748 | $782,741,004 | 0.01% | |
| 3. | 2,421,125 | $297,798,375 | 0.01% | |
| 4. | 1,397,284 | $171,865,938 | 0.01% | |
| 5. | 1,312,771 | $161,470,833 | 0.04% |
News See All
Jazz Pharmaceuticals plc (NASDAQ:JAZZ) Q1 2024 Earnings Call Transcript
Operator: Thank you for standing by. My name is Krista, and I will be your conference operator today.
Following the Money Trail: Where are Hedge Funds Investing?
For years, investors have chased the latest tech darlings, throwing money at overvalued companies based on hype and empty promises. At Insider Monkey we do things a little bit different.
5 High Growth Value Stocks to Invest in According to Seth Klarman
In this piece, we will take a look at the five high growth value stocks to invest in according to Seth Klarman.
30 Biggest Biotechnology Companies in the World
In this article, we will be taking a look at the 30 biggest biotechnology companies in the world.
5 Stocks Insiders are Buying Now
Satellite communication and internet services company EchoStar Corp (NASDAQ:SATS) ranks fifth in our list of the stocks with the highest insider purchasing activity recently.
5 Biotech Stocks with Huge Potential
In this article, we will take a look at the 5 biotech stocks with huge potential.
5 Mid-Cap Stocks with Insider Purchases
Infusion therapy and care company Option Care Health Inc (NASDAQ:OPCH) is one of the mid-cap stocks which recently saw insider purchases.
Jazz Pharmaceuticals plc (NASDAQ:JAZZ) Q4 2023 Earnings Call Transcript
Jazz Pharmaceuticals plc misses on earnings expectations. Reported EPS is $5.02 EPS, expectations were $5.26.
Billionaire Hedge Funds
